Thus, it is likely that the decline of NAD+ levels, aggravated by COVID-19, increases the activity of NLRP3 and triggers cytokine storms in COVID-19 patients; restoring normal NAD+ levels likely alleviates COVID-19 symptoms. The gene discussed is NLRP3; the disease is COVID-19.